Stock Scorecard
Stock Summary for ClearPoint Neuro Inc (CLPT) - $5.40 as of 4/25/2024 7:29:45 AM EST
Total Score
7 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CLPT
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CLPT
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CLPT
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for CLPT
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for CLPT
Financial Details for CLPT
Company Overview |
|
---|---|
Ticker | CLPT |
Company Name | ClearPoint Neuro Inc |
Country | USA |
Description | ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/9/2024 |
Stock Price History |
|
Last Day Price | 5.40 |
Last Day Price Updated | 4/25/2024 7:29:45 AM EST |
Last Day Volume | 0 |
Average Daily Volume | 147,858 |
52-Week High | 10.80 |
52-Week Low | 4.05 |
Last Price to 52 Week Low | 33.33% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 47.46 |
Sector PE | 60.54 |
5-Year Average PE | -14.85 |
Free Cash Flow Ratio | 6.35 |
Industry Free Cash Flow Ratio | 61.03 |
Sector Free Cash Flow Ratio | 30.19 |
Current Ratio Most Recent Quarter | 4.87 |
Total Cash Per Share | 0.85 |
Book Value Per Share Most Recent Quarter | 0.86 |
Price to Book Ratio | 7.44 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 6.57 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 27,069,600 |
Market Capitalization | 146,175,840 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -34.40% |
Reported EPS 12 Trailing Months | -0.90 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.91 |
Net Income Twelve Trailing Months | -22,089,000 |
Net Income Past Year | -22,089,000 |
Net Income Prior Year | -16,435,000 |
Quarterly Revenue Growth YOY | 31.60% |
5-Year Revenue Growth | 26.64% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 23,140,000 |
Total Cash Past Year | 23,140,000 |
Total Cash Prior Year | 37,489,000 |
Net Cash Position Most Recent Quarter | 13,191,000 |
Net Cash Position Past Year | 13,191,000 |
Long Term Debt Past Year | 9,949,000 |
Long Term Debt Prior Year | 9,893,000 |
Total Debt Most Recent Quarter | 9,949,000 |
Equity to Debt Ratio Past Year | 0.68 |
Equity to Debt Ratio Most Recent Quarter | 0.68 |
Total Stockholder Equity Past Year | 21,173,000 |
Total Stockholder Equity Prior Year | 36,887,000 |
Total Stockholder Equity Most Recent Quarter | 21,173,000 |
Options |
|
Put/Call Ratio | 0.08 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.36 |
MACD Signal | -0.26 |
20-Day Bollinger Lower Band | 5.42 |
20-Day Bollinger Middle Band | 6.64 |
20-Day Bollinger Upper Band | 7.86 |
Beta | 0.92 |
RSI | 30.24 |
50-Day SMA | 6.35 |
200-Day SMA | 10.98 |
System |
|
Modified | 4/24/2024 9:16:29 PM EST |